Literature DB >> 24744593

Combined laparoscopic spleen-preserving distal pancreatectomy and islet autotransplantation for benign pancreatic neoplasm.

Gianpaolo Balzano1, Michele Carvello1, Lorenzo Piemonti1, Rita Nano1, Riccardo Ariotti1, Alessia Mercalli1, Raffaella Melzi1, Paola Maffi1, Marco Braga1, Carlo Staudacher1.   

Abstract

AIM: To evaluate the safety and feasibility of laparoscopic spleen-preserving distal pancreatectomy (LSPDP) with autologous islet transplantation (AIT) for benign tumors of the pancreatic body-neck.
METHODS: Three non-diabetic, female patients (age 37, 44 and 35 years, respectively) were declared candidates for surgery, between May and September 2011, because of pancreatic body/neck cystic lesions. The planned operation was an LSPDP associated with AIT from the normal pancreas distal to the neoplasm. Islets isolation was performed on the residual pancreatic parenchyma after frozen section examination of the margin. Purified autologous islets were infused into the portal vein by a percutaneous transhepatic approach the day after surgery.
RESULTS: The procedure was performed successfully in all the three cases, and the spleen was preserved along with its vessels. Mean operation time was 283 ± 52 min and average blood loss was 133 ± 57 mL. Residual pancreas weights were 33, 22 and 30 g, and 105.200, 40.390 and 94.790 islet equivalents were isolated, respectively. Surgical complications occurred in one patient (grade A pancreatic fistula). Postoperative stays were 6, 6 and 7 d, respectively. Histopathological evaluation revealed mucinous cystic neoplasm in cases 1 and 3, and serous cystic neoplasm in patient 2. No postoperative insulin administration was required. One patient developed a transient partial portal thrombosis 2 mo after islet infusion. Patients are insulin independent at a mean follow up of 8 ± 2 mo.
CONCLUSION: Combination of LSPDP and AIT is feasible and could be effective to minimize the surgical impact for benign neoplasm of pancreatic body-neck.

Entities:  

Keywords:  Autologous islet transplantation; Benign neoplasm; Laparoscopy; Minimally invasive treatment; Pancreas; Pancreatogenic diabetes; Spleen preservation

Mesh:

Year:  2014        PMID: 24744593      PMCID: PMC3983459          DOI: 10.3748/wjg.v20.i14.4030

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution.

Authors:  P Villiger; E A Ryan; R Owen; K O'Kelly; J Oberholzer; F Al Saif; T Kin; H Wang; I Larsen; S L Blitz; V Menon; P Senior; D L Bigam; B Paty; N M Kneteman; J R T Lakey; A M James Shapiro
Journal:  Am J Transplant       Date:  2005-12       Impact factor: 8.086

2.  Laparoscopic three-port distal pancreatectomy.

Authors:  Gokulakkrishna Subhas; Natasha Gupta; Vijay K Mittal; Michael J Jacobs
Journal:  HPB (Oxford)       Date:  2011-03-22       Impact factor: 3.647

3.  Laparoscopic central pancreatectomy.

Authors:  Elena Orsenigo; Paolo Baccari; Guido Bissolotti; Carlo Staudacher
Journal:  Am J Surg       Date:  2006-04       Impact factor: 2.565

4.  Islet autotransplantation after extended pancreatectomy for focal benign disease of the pancreas.

Authors:  Frédéric Ris; Nadja Niclauss; Philippe Morel; Sandrine Demuylder-Mischler; Yannick Muller; Raphael Meier; Muriel Genevay; Domenico Bosco; Thierry Berney
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

Review 5.  Primary pancreatic cystic neoplasms revisited: part II. Mucinous cystic neoplasms.

Authors:  George H Sakorafas; Vasileios Smyrniotis; Kaye M Reid-Lombardo; Michael G Sarr
Journal:  Surg Oncol       Date:  2011-01-19       Impact factor: 3.279

Review 6.  ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts.

Authors:  Asif Khalid; William Brugge
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

Review 7.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

8.  Distal pancreatectomy: incidence of postoperative diabetes.

Authors:  Jonathan King; Kevork Kazanjian; J Matsumoto; Howard A Reber; Michael W Yeh; O Joe Hines; Guido Eibl
Journal:  J Gastrointest Surg       Date:  2008-06-10       Impact factor: 3.452

9.  A central pancreatectomy for benign or low-grade malignant neoplasms.

Authors:  Seiko Hirono; Masaji Tani; Manabu Kawai; Shinomi Ina; Ryohei Nishioka; Motoki Miyazawa; Atsushi Shimizu; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  J Gastrointest Surg       Date:  2009-06-02       Impact factor: 3.452

10.  Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism.

Authors:  Anjali F Kumar; Rainer W G Gruessner; Elizabeth R Seaquist
Journal:  Diabetes Care       Date:  2008-05-09       Impact factor: 19.112

View more
  2 in total

Review 1.  Re-engineering islet cell transplantation.

Authors:  Nicoletta Fotino; Carmen Fotino; Antonello Pileggi
Journal:  Pharmacol Res       Date:  2015-03-23       Impact factor: 7.658

Review 2.  [Minimally invasive and robot-assisted surgery for pancreatic cystic tumors].

Authors:  T Welsch; M Distler; J Weitz
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.